Home › Funds › Cormorant Asset Management, LP › BIOA

Cormorant Asset Management, LP position in BIOA

BIOAGE LABS INC · Health Care

Cormorant Asset Management, LP reported holding 2,390,605 shares of BIOA (BIOAGE LABS INC) in its Q2 2026 13F filing — a position valued at US$58.6M, representing 3.00% of its reported portfolio and ranking #13 among its reported holdings. Cormorant Asset Management, LP has disclosed BIOA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)2.39M sh
Reported value held$58.59M
Portfolio Weight3.00%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's BIOA position evolved

Cormorant Asset Management, LP first disclosed a stake in BIOA in Q3 2024 at 1,629,529 shares (US$33.9M). The position peaked in Q2 2026 at 2,390,605 shares, worth US$58.6M. Across 8 filings, Cormorant Asset Management, LP increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 2,390,605 shares valued at US$58.6M — a reduction of -500,000 shares quarter over quarter.. Notable position changes include a 61% increase in Q4 2024 (shares fell 35% over the following quarter), a 42% increase in Q1 2026 (shares rose 40% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 1.63M $33.89M New
Q4 2024 2.63M $15.22M Add
Q1 2025 2.63M $9.89M Hold
Q2 2025 2.14M $8.84M Reduce
Q3 2025 2.14M $12.59M Hold
Q4 2025 2.04M $27.00M Reduce
Q1 2026 2.89M $50.56M Add
Q2 2026 2.39M $58.59M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIOA and 13F data

BIOA (BIOAGE LABS INC) is a Health Care company. 78 other funds we track also report a position in BIOA — the largest reported positions include a16z Capital Management, L.L.C. (US$79.2M), Sofinnova Investments, Inc. (US$56.2M), Octagon Capital Advisors LP (US$42.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIOA

All BIOA fund holders →

FAQ

How long has Cormorant Asset Management, LP held BIOA?

Cormorant Asset Management, LP has disclosed BIOA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Cormorant Asset Management, LP's current position in BIOA?

As of Q2 2026, Cormorant Asset Management, LP holds 2.39M shares of BIOA (BIOAGE LABS INC), valued at $58.59M, representing 3.00% of its reported portfolio and ranking #13.

Has Cormorant Asset Management, LP been buying or selling BIOA?

In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP reduced its position in BIOA. The position peaked in Q2 2026 at 2.39M shares.

Which other funds hold BIOA?

Other major institutional holders of BIOA include a16z Capital Management, L.L.C., Sofinnova Investments, Inc., Octagon Capital Advisors LP, among 78 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.